Cargando…
Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
BACKGROUND: Childhood and adolescent drug-resistant TB (DR-TB) is one of the neglected infectious diseases. Limited evidence exists around programmatic outcomes of children and adolescents receiving DR-TB treatment. The study aimed to determine the final treatment outcomes, culture conversion rates...
Autores principales: | Dhakulkar, Shubhangi, Das, Mrinalini, Sutar, Narendra, Oswal, Vikas, Shah, Daksha, Ravi, Shilpa, Vengurlekar, Dipa, Chavan, Vijay, Rebello, Lorraine, Meneguim, Augusto C., Iyer, Aparna, Mansoor, Homa, Kalon, Stobdan, Acharya, Shrikala, Ferlazzo, Gabriella, Isaakidis, Petros, Thakur, Harshad P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891761/ https://www.ncbi.nlm.nih.gov/pubmed/33600431 http://dx.doi.org/10.1371/journal.pone.0246639 |
Ejemplares similares
-
Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
por: Das, Mrinalini, et al.
Publicado: (2021) -
Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India
por: Laxmeshwar, Chinmay, et al.
Publicado: (2020) -
Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges
por: Chavan, Vijay Vinayak, et al.
Publicado: (2020) -
Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
por: Paryani, Roma Haresh, et al.
Publicado: (2020) -
GeneXpert and Community Health Workers Supported Patient Tracing for Tuberculosis Diagnosis in Conflict-Affected Border Areas in India
por: Das, Mrinalini, et al.
Publicado: (2019)